Merck KGaA acquires Germany-based mRNA contract manufacturer

Merck KGaA acquires Germany-based mRNA contract manufacturer
WESPECH PTE LTD
8 Eu Tong Sen Street #14-94, The Central, Singapore (059818)
+65 315 904 24

25.01.2021

MOSCOW (MRC) -- Merck KGaA says it has acquired AmpTec (Hamburg, Germany), a messenger RNA (mRNA) contract development and manufacturing organization (CDMO), according to Chemweek. The deal strengthens Merck's capabilities to develop and manufacture mRNA for its customers, for use in vaccines, treatments, and diagnostics applicable in COVID-19 and many other diseases, the company says. Fi

Full article at mrcplast.com

Back

news